Filing Details

Accession Number:
0000874015-20-000076
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-26 19:47:17
Reporting Period:
2020-06-24
Accepted Time:
2020-06-26 19:47:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874015 Ionis Pharmaceuticals Inc IONS Pharmaceutical Preparations (2834) 330336973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
897667 T Stanley Crooke C/O Ionis Pharmaceuticals, Inc
2855 Gazelle Court
Carlsbad CA 92010
Exec Chairman Of The Board Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-06-24 5,000 $58.80 11,935 No 4 S Direct
Common Stock Disposition 2020-06-25 9,914 $60.11 2,021 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 700,391 Indirect By Trust
Footnotes
  1. Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on January 2, 2020.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.10 to $60.15, inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4